You are here: Home > News > The EFPIA Disclosure Experience: An Update

The EFPIA Disclosure Experience: An Update

EFPIA offers an update on media and industry responses

Nine months on from the 2016 European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code deadline — which required all member companies across Europe to publish data concerning their 2015 transfer-of-value transactions to healthcare professionals (HCPs) — EFPIA Director of Communications Andrew Powrie-Smith offered a lively update on the responses to the Code to a highly engaged audience at last week’s CBI’s Global Transparency Reporting Congress in London.

Having monitored the media reaction to the first wave of disclosures (or attempts at disclosure), Powrie-Smith pointed to generally neutral coverage across Europe, the negative perspectives tempered largely by time constrictions on reporting before the data could be properly analysed and, in many cases, a lack of understanding about what the data actually meant. When the media commentators have had time to grasp more fully the nature of transfer-of-value disclosures and begins to drill down in more detail—focusing on individual HCPs and prescribing data, for example—Powrie-Smith said that the coverage will likely become more informed and critical.